Search
Showing 1 - 17 of 17 results
There’s a More Humane Way to Monitor Crohn's and Colitis Patients
IBD, which comprises Crohn’s disease and ulcerative colitis, affects 1.3% of the U.S. population and accounts for 3 million new diagnoses every year.First-line Pembrolizumab Plus Chemotherapy May Benefit Patients with Advanced Biliary Tract Cancers
The addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untreated metastatic or unresectable biliary tract cancer, according to results from the phase III KEYNOTE-966 clinical trial.Alcohol-Associated Liver Disease Program
UCSF HEPATOLOGY AND LIVER TRANSPLANT SERVICES have established the Alcohol-Associated Liver Disease Program, expanding access to hepatology care and liver transplantation for a broader range of patients.Primary Care of the IBD Patient: Risk Factors, Symptoms and the Value of Timely Therapeutics
In this update on inflammatory bowel disease, gastroenterologist Kendall Beck, MD, notes contributing causes, explains which tests have value, gives keys to distinguishing ulcerative colitis and Crohn’s...Research Reveals Mechanisms at Work in Progression of Pancreatic Cysts to Pancreatic Cancer
Tumor Immune Microenvironments May Provide Clues to Future TherapiesUCSF Develops First of Its Kind Robotic Surgery Trial in Partnership with FDA
UCSF Health is recruiting patients for the only FDA-approved study of the use of single port robotic technology for colorectal surgery in the United States.Strategies for Reducing Length of Hospital Stay for Patients With Acute Severe Ulcerative Colitis
In a first-of-its-kind study, UCSF researchers assessed factors prolonging length of stay (LOS) for a diverse population of hospitalized patients with acute severe ulcerative colitis (ASUC) and identified interventions to reduce LOS for these patients.The Evidence on Incidentalomas: When to Investigate, When to Rest Easy
This presentation from radiologist Hailey H. Choi, MD, supplies straightforward criteria to help providers assess lesions ranging from thyroid and adrenal nodules to ovarian cysts to pancreatic and liver lesions.Genetic Gut Microbiome Variations Point to Precision Treatments for Metabolic Conditions
In a new study, UCSF researchers found that the gut microbiome of East Asians is distinct from that of White individuals living in the same geographic region. This discovery may lead to personalized treatments for various metabolic conditions, including diabetes and obesity.A Guide to GERD: Managing Symptoms and Complications of a Common Condition
With gastroesophageal reflux disease affecting 40% of the U.S. population every month, primary care providers need a straightforward plan for initiating therapy, as well as an up-to-date understanding of causes and treatment complications.Endoscopic Removal of Benign Complex Colorectal Lesions Improves Patient Outcomes
Endoscopic mucosal resection (EMR) is a safe and effective alternative to surgery for benign complex colorectal lesions, according to research led by UCSF gastroenterologist Tonya Kaltenbach, MD.Liver Transplant Program and Referral Information
With more than 13,000 people in the United States with end-stage liver disease awaiting a liver transplant,UCSF has made liver transplantation services a high priority.Manipulating Gut Microbiomes to Treat inflammatory Bowel Disease
Researchers at the Benioff Center for Microbiome Medicine at UCSF are working to accelerate understanding of how microbes promote health and prevent disease and to leverage this information to develop novel, effective treatments in the shortest possible time.Understanding Obesity: Essentials of Screening and Management in Primary Care
Weight management specialist Diana Thiara, MD, presents an update on obesity care, with guidance on using screening tools, having sensitive discussions, and selecting treatments – from dietary modifications to surgery.New Practice Guidance on Malnutrition, Frailty and Sarcopenia in Patients With Cirrhosis, Led by UCSF Researcher
The first-ever American Association for the Study of Liver Diseases (AASLD) Practice Guidance on the management of malnutrition, frailty and sarcopenia in patients with cirrhosis is now available.Constipation Frustration: How to Determine Therapy for a Diverse Diagnosis
A common disorder with a heavy socioeconomic burden, constipation has numerous causes and is described differently by different patients.Colon Cancer: New Screening Options and Guidelines
With colon cancer increasingly found in younger patients as well as a leading cause of cancer-related death, Aparajita Singh, MD, MPH, director of the UCSF GI Cancer Prevention Program, offers an important update.